These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 16924594)
21. Stratification of patients by melanoma cell adhesion molecule (MCAM) expression on the basis of risk: implications for sentinel lymph node biopsy. Pearl RA; Pacifico MD; Richman PI; Wilson GD; Grover R J Plast Reconstr Aesthet Surg; 2008; 61(3):265-71. PubMed ID: 17569608 [TBL] [Abstract][Full Text] [Related]
22. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma. Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123 [TBL] [Abstract][Full Text] [Related]
23. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases. Boyd AS; Shakhtour B; Shyr Y J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467 [TBL] [Abstract][Full Text] [Related]
24. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma. Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039 [TBL] [Abstract][Full Text] [Related]
25. Macrophage migration inhibitory factor protein and mRNA expression in cutaneous melanocytic tumours. Miracco C; De Nisi MC; Arcuri F; Cosci E; Pacenti L; Toscano M; Lalinga AV; Biagioli M; Rubegni P; Vatti R; Maellaro E; Del Bello B; Massi D; Luzi P; Tosi P Int J Oncol; 2006 Feb; 28(2):345-52. PubMed ID: 16391788 [TBL] [Abstract][Full Text] [Related]
26. Expression of the ets-1 proto-oncogene in melanocytic lesions. Keehn CA; Smoller BR; Morgan MB Mod Pathol; 2003 Aug; 16(8):772-7. PubMed ID: 12920221 [TBL] [Abstract][Full Text] [Related]
27. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases. Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396 [TBL] [Abstract][Full Text] [Related]
28. The use of LYVE-1 antibody for detecting lymphatic involvement in patients with malignant melanoma of known sentinel node status. Sahni D; Robson A; Orchard G; Szydlo R; Evans AV; Russell-Jones R J Clin Pathol; 2005 Jul; 58(7):715-21. PubMed ID: 15976338 [TBL] [Abstract][Full Text] [Related]
30. Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma. Prieto VG; Mourad-Zeidan AA; Melnikova V; Johnson MM; Lopez A; Diwan AH; Lazar AJ; Shen SS; Zhang PS; Reed JA; Gershenwald JE; Raz A; Bar-Eli M Clin Cancer Res; 2006 Nov; 12(22):6709-15. PubMed ID: 17121890 [TBL] [Abstract][Full Text] [Related]
31. Tumor lymphangiogenesis and melanoma metastasis. Rinderknecht M; Detmar M J Cell Physiol; 2008 Aug; 216(2):347-54. PubMed ID: 18481261 [TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of isolated HMB45 or Melan A positive cells in Melanoma sentinel lymph nodes. Satzger I; Völker B; Meier A; Schenck F; Kapp A; Gutzmer R Am J Surg Pathol; 2007 Aug; 31(8):1175-80. PubMed ID: 17667539 [TBL] [Abstract][Full Text] [Related]
33. mRNA expression and protein distribution of the unspliced tenascin-C isoform in prostatic adenocarcinoma. Katenkamp K; Berndt A; Hindermann W; Wunderlich H; Haas KM; Borsi L; Zardi L; Kosmehl H J Pathol; 2004 Jul; 203(3):771-9. PubMed ID: 15221936 [TBL] [Abstract][Full Text] [Related]
34. Increased p21-activated kinase-1 expression is associated with invasive potential in uveal melanoma. Pavey S; Zuidervaart W; van Nieuwpoort F; Packer L; Jager M; Gruis N; Hayward N Melanoma Res; 2006 Aug; 16(4):285-96. PubMed ID: 16845324 [TBL] [Abstract][Full Text] [Related]
35. Tetranectin and plasmin/plasminogen are similarly distributed at the invasive front of cutaneous melanoma lesions. De Vries TJ; De Wit PE; Clemmensen I; Verspaget HW; Weidle UH; Bröcker EB; Ruiter DJ; Van Muijen GN J Pathol; 1996 Jul; 179(3):260-5. PubMed ID: 8774480 [TBL] [Abstract][Full Text] [Related]
36. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas. Fröhlich E; Mack AF; Garbe C; Klessen C Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652 [TBL] [Abstract][Full Text] [Related]
37. Towards defining roles and relationships for tenascin-C and TGFbeta-1 in the normal and neoplastic urinary bladder. Booth C; Harnden P; Selby PJ; Southgate J J Pathol; 2002 Nov; 198(3):359-68. PubMed ID: 12375269 [TBL] [Abstract][Full Text] [Related]
38. Co-expression of tenascin and fibronectin in epithelial and stromal cells of benign lesions and ductal carcinomas in the human breast. Yoshida T; Matsumoto E; Hanamura N; Kalembeyi I; Katsuta K; Ishihara A; Sakakura T J Pathol; 1997 Aug; 182(4):421-8. PubMed ID: 9306963 [TBL] [Abstract][Full Text] [Related]
39. JARID1B expression in human melanoma and benign melanocytic skin lesions. Kuźbicki L; Lange D; Strączyńska-Niemiec A; Chwirot BW Melanoma Res; 2013 Feb; 23(1):8-12. PubMed ID: 23262439 [TBL] [Abstract][Full Text] [Related]